Although this may sound like something out of the "don’t do it because you’ll go blind" book of sexual repression, it’s not a joke. According to a report published in the January issue of BJU International, men who are very sexually active in their 20s and 30s, especially if they masturbate frequently, have a higher risk of developing prostate cancer.
BUT – men in their 50s who have even infrequent sexual activity actually decrease their risk of developing prostate cancer.
According to the study, which looked at 800 men:
frequent sex in 20s and 30s: not good
frequent sex in 40s: no health impact re prostate
sex in 50s: good
The important point also was not intercourse, but the frequency of masturbation.
I would be very interested in reading the study in w…

Original post by Cancer Commentary and software by Elliott Back

CANADIAN SITES – NATIONAL

Canadian Prostate Cancer Research Initiative
CPCN was a founding member of this organization, dedicated to facilitating innovative research in the areas of prevention, early detection, diagnosis, treatment, rehabilitation and palliation for people affected by prostate cancer.

Canadian Prostate Health Council
This is an excellent source for online pamphlets on prostate cancer and prostate health.

ProCure
ProCure is dedicated to giving information on the prevention, diagnosis, treatment, and eventual cure of prostate cancer. Headquartered in Montreal, Canada, it provides both French and English resources. Excellent web site.

Prostate Cancer Research Foundation of Canada
This organization, committed to finding a cure for prostate cancer, provides information in both English and French.

The Prostate Centre at Princess Margaret Hospital, Toronto
This Centre provides excellent online information about the prostate and prostate cancer.

The Prostate Centre at Vancouver General Hospital, British Columbia
The website offers information on prostate cancer treatment and research.

The Prostate Centre, Victoria, British Columbia
The efforts of prostate cancer survivors did much to make this facility happen.

CANADIAN SITES—PROVINCIAL

British Columbia Foundation for Prostate Disease
This organization’s goal is to improve knowledge, prevention, and treatment of prostate cancer.

Calgary Prostate Cancer Institute
The Institute provides current information about prostate disease, research findings and treatment options as well as diagnostic services, confidential counselling and support.

Early Prostate Diagnosis Ontario
EPCDO’s goals are to tell people about the value of early diagnosis of prostate cancer through the PSA blood test (combined with physical tests), and to convince OHIP to cover the cost of these tests when carried out in a doctor’s office or at a testing lab.

Vancouver Island Prostate Cancer Foundation
The site provides information for the recently diagnosed, including information about support and advocacy.

(more…)

The Canadian Prostate Cancer Network speaks for thousands of men and their families who, each year, are diagnosed with prostate cancer. With our 120 affiliated support groups across Canada we:

	help individuals and their families understand and cope with prostate cancer by providing up to date medical information and individual support
	lobby for increased funding for research, treatment facilities and programs
	promote the importance of early detection through public awareness campaigns

The prostate is a gland about the size and shape of a walnut. The prostate gland is located in front of the rectum, just below the bladder and it surrounds the urethra. The urethra carries urine from the bladder out through the penis.

A gene responsible for spreading breast cancer and making tumors resistant to chemotherapy has been identified by scientists from Princeton University.
The “metastasis gene” called Metadherin, or MTDH is turned on in 40% of breast cancer tumors. It is also found in 20% of prostate cancer patients studied. The gene helps spread cancer by making the tumor cells stick to blood vessels that bring them to distant areas of the body. MTDH also makes the tumors more resistant to chemotherapy drugs.
Discovering this gene helps scientist “hit two birds in one stone”, says senior author Dr. Yibin Kang to Newsday. “If you come up with a therapy that inhibits the gene, it could make the tumor more susceptible to chemotherapy and at the same time reduce the chance for a t…

Original post by Genetics and Health and software by Elliott Back

On December 24, 2008 the US Food & Drug Administration granted tentative approval to Accord Healthcare’s bicalutamide.
Accord is a subsidiary of Intas Pharmaceuticals, Ltd., an Indian company. Accord’s function is licensing and marketing.
According to the FDA, this is the definition of “tentative approval”:
“If a generic drug product is ready for approval before the expiration
of any [...] (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back

Ok, pop quiz: What do these men have in common?
Former Secretary of State Colin Powell
Singer Harry Belafonte
Golfer Arnold Palmer
Former South African President Nelson Mandela
Musician Frank Zappa
Answer…
They all had prostate cancer.
Breast cancer is talked about all the time among the rich and famous, so it seems, but prostate cancer – not so much. Luckily, there are famous men who are speaking out about their diagnosis and battles with the disease. The more who talk, hopefully the more men will get the message about prostate cancer screening.
Colin Powell had localized prostate cancer for which he had surgery in 2003. He was 66 at the time of diagnosis and all seems well up to now.
In 1997, Harry Belafonte was the subject of this very interesting article on his battle with pros…

Original post by Cancer Commentary and software by Elliott Back

Dr. Gleason died December 28, 2008 at the age of 88.
Here is a link to the obituary:
http://www.startribune.com/obituaries/3 … iaec8O7EyU
or
http://tinyurl.com/9g5o2o
The stature of this pioneer is simply incalculable.
Rest in Peace.
Steve (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back

Recent stories on bisphosphonate side effects might be signaling the advent of a new, superior drug, but will Halozyme’s rHuPH20 enzyme solve the problem of jaw necrosis?
Drug development companies operate within the overall consumer culture. We all want better drugs, better everything. Generic Fosamax (alendronate) now costs just $4 at Wal-Mart, Kroger and [...] (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back